Show simple item record

dc.contributor.authorJ. Stewart, Trina
dc.contributor.authorI. Abrams, Scott
dc.date.accessioned2017-05-03T16:13:12Z
dc.date.available2017-05-03T16:13:12Z
dc.date.issued2007
dc.date.modified2013-12-12T03:29:28Z
dc.identifier.issn00221767
dc.identifier.urihttp://hdl.handle.net/10072/54903
dc.description.abstractAg-specific and generalized forms of immunosuppression have been documented in animal tumor models. However, much of our knowledge on tumor-induced immunosuppression was acquired using tumor implant models, which do not reiterate the protracted nature of host-tumor interactions. Therefore, a transgenic mouse model of autochthonous mammary tumor development and progression was chosen to investigate the long-term consequences of neoplastic growth on the immune system. In vitro proliferation of unfractionated splenocytes from tumor-bearing mice, as assessed by [3H]thymidine uptake, was inhibited by the presence of suppressor cells within these splenocyte preparations, because purifying the T cells restored their biological activity. However, the level of inhibition did not correlate with either tumor load or the percentage of myeloid-derived CD11b Gr1 cells. To evaluate tumor-specific immune dysfunction, transgenic mice were challenged with autologous tumor cells. Mice with extensive, but not minimal autochthonous tumor burdens demonstrated a significantly enhanced rate of autologous tumor growth compared with age-matched controls. In contrast, an allogeneic tumor challenge was efficiently rejected from both groups of transgenic mice. It was also noted that allogeneic tumor challenge of mice with minimal disease significantly inhibited autochthonous primary tumor growth. We therefore demonstrated that 1) a generalized form of immunosuppression occurred, but not as a result of permanent alterations to T cell function, because purified T cell subsets retained normal biological activity following polyclonal or allostimulation; and 2) tumor-specific immunosuppression emerged as a consequence of tumor progression, but could be modulated to enhance antitumor responses against autochthonous primary neoplastic growth.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.languageEnglish
dc.language.isoeng
dc.publisherAmerican Association of Immunologists
dc.publisher.placeUnited States
dc.publisher.urihttp://www.jimmunol.org/content/179/5/2851.abstract
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom2851
dc.relation.ispartofpageto2859
dc.relation.ispartofissue5
dc.relation.ispartofjournalJournal of Immunology
dc.relation.ispartofvolume179
dc.rights.retentionY
dc.subject.fieldofresearchTumour Immunology
dc.subject.fieldofresearchImmunology
dc.subject.fieldofresearchcode110709
dc.subject.fieldofresearchcode1107
dc.titleAltered Immune Function during Long-Term Host-Tumor Interactions Can Be Modulated to Retard Autochthonous Neoplastic Growth
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.rights.copyrightSelf-archiving of the author-manuscript version is not yet supported by this journal. Please refer to the journal link for access to the definitive, published version or contact the author[s] for more information.
gro.date.issued2007
gro.hasfulltextNo Full Text
gro.griffith.authorStewart, Trina


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record